[{"Assets_0_Q3_USD":269856000.0,"CommonStockSharesOutstanding_0_Q3_shares":24046435.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-33049000.0,"NetIncomeLoss_1_Q3_USD":-10172000.0,"NetIncomeLoss_3_Q3_USD":-28318000.0,"StockholdersEquity_0_Q3_USD":254622000.0,"Ticker":"IGMS","CIK":"1496323","name":"IGM BIOSCIENCES, INC.","OfficialName":"IGM Biosciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"806397058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]